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Introduction
Traumatic brain injury serves as a major cause of death and 
disability. Over one million people are treated for traumatic 
brain injury in emergency rooms in America each year. Fifty 
thousand die as a result, while seventy to ninety thousand are 
left with debilitating long term neurological impairment. Among 
men under the age of 35, traumatic brain injury as a result of 
vehicular accident is the leading cause of death and disability 
(Shear, et al. 2002). Besides for the direct effects of the primary 
injury, outcomes are affected by the onset of secondary insult. 
Such insult includes the onset of hypoxia, hypotension, and an 
increase in intracranial pressure, which is often due to cranial 
edema. Hypotension has been correlated with a mortality rate 
which is double that of patients without the condition (Cooper, 
et al. 2004; Cooper, et al. 2012; Shackford, et al. 1998). As yet, no 
pharmacologic agent has been proven to improve the outcome 
of traumatic brain injury, notwithstanding the intense efforts of 
many researchers. To date, the management of traumatic brain 
injury consists of preventing further neurologic insults, manag-
ing intracranial pressure, and instituting surgical procedures to 
minimize damage (Shear, et al. 2002; Wright, et al. 2007; Xiao, et 
al. 2008). 
The severity of a traumatic brain injury is universally measured 
according to the Glasgow Coma Scale, which assesses eye, ver-
bal and motor condition following the injury. The scale which is 
most often used is the Extended Glasgow Coma Scale, which 
ranges from 3 to 15, awarding points for various functions which 
can be achieved. A score on the Glasgow Coma Scale of 3 in-
dicates death or a deep coma, while a 15 indicates complete 
consciousness. 
The outcome of traumatic brain injury is universally assessed 
according to the Extended Glasgow Outcome Scale, which is 
highly sensitive. It consists of eight diagnoses, which are: Dead, 
Vegetative State, Lower Severe Disability, Upper Severe Disability, 
Lower Moderate Disability, Upper Moderate Disability, Lower 
Good Recovery, and Upper Good Recovery This study aims to 
analyze and assess the effectiveness of three of the current acute 
responses to traumatic brain injury, including both chemical and 
surgical options. Methods used to decrease intracranial pressure 
include hypertonic saline resuscitation and the administration of 
progesterone, which has been touted as a neuroprotector. The 
performance of decompressive craniectomy has also been fac-
tored into this study. 
Hypertonic Saline
Hypertonic saline is administered intravenously, often en route 
to the hospital. The underlying claim to the administration of 
hypertonic saline is that it restores systemic blood pressure 
and cardiac output to manageable levels with less volume being 
necessary than when using the standard Lactated Ringer’s solu-
tion. The hypertonic saline extracts water from the intracellular 
space in order to restore intravascular losses and it has a positive 
inotropic effect on cardiac output. In addition, hypertonic saline 
has been shown to improve oxygen transport, mesenteric and 
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Eye Opening Response
Spontaneous-open with blinking at 
baseline
4 Points
Opens to verbal command, speech, 
or shout
3 Points




Confused conversation, but able to 
answer questions
4 Points
Inappropriate responses, words 
discernable
3 Points
Incomprehensible speech 2 Points
None 1 Points
Motor Response
Obeys commandes for movement 6 Points
Purposeful movement to painful 
stimulus
5 Points
withdraws from pain 4 Points
Abnormal (spastic) flexion, decorti-
cate posture
3 Points




Extended Glasgow Outcome Scale
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coronary blood flow, myocardial contractility, and redistribu-
tion of extracellular and interstitial fluid (Mattox, et al. 1991; 
Shackford, et al. 1998).
Progesterone
Progesterone is administered in a similar fashion to hypertonic 
saline. The concept of using progesterone to alleviate problems 
caused by traumatic brain injury was discovered when research-
ers noticed a significant sex difference in trauma outcome in 
correlation to hormonal cycling. Female rats with elevated 
levels of progesterone showed reduced tissue damage and im-
proved behavioral recovery (Shear, et al. 2002). As progesterone 
has been used safely on humans for years, it was hoped that 
it would have a positive effect on people with traumatic brain 
injury (Wright, et al. 2007). While the mechanism is unknown as 
of yet, progesterone has been shown to reduce cerebral edema, 
prevent neuronal loss, improve functional outcome, and inhibit 
oxidative damage in the central nervous system. It might also 
promote peripheral remyelination of axons following injury. 
Progesterone is lipid soluble, so it rapidly crosses the blood-
brain barrier to reach equilibrium within an hour of adminis-
tration (Shear, et al. 2002; Wright, et al. 2007; Xiao, et al. 2008). 
Decompressive Craniectom
Decompressive craniectomy is a surgical measure which is taken 
when patients present with dangerously high intracranial pres-
sure. Part of the skull is removed to allow room for the brain 
to swell. Proponents of decompressive craniectomy state that it 
can relieve uncontrollable intracranial pressure by increasing the 
volumetric capacity of the intracranial cavity. Craniectomies have 
been performed since the early nineteenth century, with varying 
degrees of success (Akyuz, et al. 2010; Morgalla, et al. 2008).
Methods
This study was performed through analyzation of published orig-
inal studies on the effects of hypertonic saline, progesterone, and 
decompressive craniectomy on traumatic brain injury. Sources 
include TouroLib databases, PubMed databases, and the archives 
of Lancet.
Discussion
Hypertonic saline was found in all cases to be safe for use. 
Shackford, et al. (1998) do caution that solutions that are too 
hypertonic are liable to reversibly open the blood-brain barri-
er, cause cerebral edema, and increase intracranial pressure. 
However, great care is taken to assure that proper proportions 
are used. Solutions that are 7.5% hypertonic saline have been 
shown to be both safe and effective (Bulger, et al. 2010; Cooper, 
et al. 2004; Mattox, et al. 1991). Administration of hypertonic sa-
line causes a slight increase in intracranial compliance, as shown 
by a decrease in mean intracranial pressure in patients receiving 
hypertonic saline, as compared to a positive trend in the intra-
cranial pressure of patients receiving Lactated Ringer’s solution. 
This data was observed on the second day following trauma 
(Shackford, et al. 1998).
When administering hypertonic saline, fluid input must be 
increased, as the saline decreases the fluid balance. No cases 
of renal failure or neurological complications due to hyperna-
tremia or hyperosmolarity have been found, but precautions 
should be taken all the same (Shackford, et al. 1998).
Patients receiving hypertonic saline showed a higher rate of nos-
ocomial infection due to the increased rate of the bloodstream. 
The increased amount of fluid output also led to a higher in-
cidence of urinary tract infections. In addition, administration 
of hypertonic saline might cause regulation of the A3 receptor 
on neutrophils, which would cause an increase in susceptibility 
to infection (Bulger, et al. 2010). Patients receiving hypertonic 
saline required a greater number of interventions to lower in-
tracranial pressure over the course of their hospitalization, but 
the difference was not significant (Shackford, et al. 1998).
While many studies have attempted to prove the superiority of 
hypertonic saline over other standard protocols, such as manni-
tol and Lactated Ringer’s solution, most have been unsuccessful. 
Out of five studies analyzed, only one study conclusively stated 
that hypertonic saline was universally preferable to mannitol. In 
that study, Battison, et al. (2005) administered four doses each 
to nine patients. Two doses were of hypertonic saline and two 
were of mannitol, in no particular order. The minimum intracra-
nial pressure was measured ten minutes before each treatment 
and was compared with the minimum intracranial pressure an 
hour after each treatment. While hypertonic saline reduced 
the intracranial pressure slightly more than mannitol did, there 
was no significant difference. The duration of the effect, how-
ever, was seen to be significantly longer in hypertonic saline. 
This study cannot be seen as conclusive, though, as it was only 
done on nine patients. In addition, the patients received both 
mannitol and hypertonic saline over a set period of time. As 
such, the effect could be due to the presence of both mannitol 
and hypertonic saline in their systems, and cannot be attributed 
solely to the hypertonic saline. 
Hypertonic saline has been shown to work slightly faster than 
controls. Cooper reports that patients receiving hypertonic sa-
line had a faster rate of decrease in intracranial pressure than 
those in the control group. However, the study also states that 
standard protocols are equally effective. All studies concur that 
there is no significant difference in favorable outcomes of pa-
tients who receive hypertonic saline and those who are treated 
with standard measures (Battison, et al. 2005; Bulger, et al. 2010; 
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Cooper, et al. 2004; Mattox, et al. 1991; Shackford, et al. 1998). 
While it may improve physiologic parameters, the long term 
benefit of administering hypertonic saline is negligible. Patients 
who received 7.5% hypertonic saline and those who received 
Lactated Ringer’s solution showed identical neurologic function 
after six months. The percentage of patients who survived to 
hospital discharge was similar. Studies found no significant dif-
ference in intracranial pressure for the duration of hospital stay, 
and there was no discernible difference in Glasgow Outcome 
Scale values. (Bulger, et al. 2010; Cooper, et al. 2004; Mattox, et 
al. 1991; Shackford, et al. 1998). 
Patients who were to undergo surgery showed a far better out-
come when given hypertonic saline in dextran (Mattox, et al. 
1991). However, at this time, hypertonic saline in dextran is quite 
expensive, as compared to the cost of standard treatments, such 
as Lactated Ringer’s solution and mannitol (Battison, et al. 2005). 
Therefore, rather than staying as a first tier response to trau-
matic brain injury, perhaps hypertonic saline should be relegated 
to a measure which is used only when surgery is indicated.
Progesterone
Aside from its long history of safe use, progesterone has been 
proven to be completely safe for use in humans. A study was 
performed with the express purpose of determining the safe-
ty of progesterone as a response to traumatic brain injury 
(Wright, et al. 2007). It was found that administration of pro-
gesterone was in no way harmful to patients, and it was indi-
cated that it might be beneficial to their recovery. Furthermore, 
endogenously released progesterone causes a 1° F increase 
in core body temperature. This deviation from standard basal 
temperature might hinder neurologic outcome in a patient with 
traumatic brain injury. However, the study found that no such 
increase in body temperature manifested in relation to admin-
istered progesterone. 
Multiple studies have found immense short term and long term 
benefits from the use of progesterone as an acute response 
to traumatic brain injury. Patients receiving progesterone had 
significantly fewer deaths due to neurologic causes. At 30 days 
postinjury, the mortality rate of patients receiving progester-
one was less than half of that of the control group (Wright, 
et al. 2007). A significant difference in neurologic outcome was 
evident up to six months post-treatment, with the experimen-
tal group having a 58% favorable outcome as compared to the 
control’s 42% (Xiao, et al. 2008). In addition, treated patients 
showed a decrease in cerebral edema, necrotic cavity forma-
tion, and neuronal loss as compared to control groups, which 
presented with neuronal and glial shrinkage and neutrophil in-
filtration. For example, necrotic cavity formation decreased by 
approximately 20% in treated patients. A decrease in apoptosis 
was noted, as well as an increase in peripheral remyelination of 
axons, an inhibition of oxidative damage in the central nervous 
system, and an overall enhanced recovery from cortical, cere-
bral, and spinal cord injury (Pan, et al. 2007; Shear, et al. 2002; 
Wright, et al. 2007; Xiao, et al. 2008). 
There has been much speculation as to the mechanism behind 
progesterone. It has been ascertained that it works, but not how 
it works. Progesterone down-regulates the inflammatory cyto-
kine cascade, which can increase the damage caused by trauma. 
Trauma causes a release of amino acids, which cause neuronal 
exitotoxicity. Progesterone might act at the GABA receptor to 
diminish that exitotoxicity (Shear, et al. 2002). The study by Pan, 
et al. (2007) posits that progesterone acts as a sigma-1 receptor 
antagonist, which can initiate the opioid-like capabilities of the 
receptor. In addition, progesterone inhibits nuclear factor kappa 
B, which is known to be a pro-inflammatory transcription factor. 
Nuclear factor kappa B is the activator of numerous inflamma-
tory cytokines, including tumor necrosis factor alpha, interleu-
kin-1 beta, C3, and glial fibrillary acidic protein. Thus, inhibition 
of nuclear factor kappa B decreases system-wide inflammation 
(Pan, et al. 2007).
The timing and duration of administration are key to the ef-
fectivity of progesterone. Most studies found a correlation 
between speedy dispensation of progesterone and favorable 
outcome. Wright et al. (2007) reports that the greatest benefit 
is gleaned when progesterone is administered within two hours 
of injury, but that there is still great advantage when it is given 
within 24 hours. Pan et al. (2007) and Shear et al. (2002) both 
started treatment within an hour of injury. It was noted that 
there is a consistent reduction in formation of cerebral edema 
when progesterone is given within 24 hours of injury (Shear, 
et al. 2002). There is a consensus that much of the success of 
progesterone is dependent upon the timing of its initiation. 
The duration of administration is slightly more controversial. 
One study, citing the contradictory effects of inflammatory cy-
tokines, limited the duration of progesterone to 24 hours. The 
researchers claimed that while immediately following an injury, 
inflammatory cytokines are neurotoxic, they are later neuropro-
tective. Seeking to block the initial harmful effect of inflammatory 
cytokines yet capitalize on their latent neuroprotective abilities, 
the study administered progesterone from 30 minutes to 24 
hours following injury, at which time they ceased administration 
of the treatment (Pan, et al. 2007). However, other studies noted 
that the greatest benefit was attained when progesterone was 
administered for five days (Shear, et al. 2002; Xiao, et al. 2008). In 
the experiment carried out by Shear, et al. (2002) on rodents, one 
group received progesterone for three days, while the other re-
ceived it for five. It was concluded that five days of progesterone 
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are necessary to achieve the desired results, namely an alleviation 
of the neuropathological and behavioral abnormalities which are 
caused by traumatic brain injury. This finding seems to contradict 
that of Pan’s. However, as harmful consequences of extending 
the progesterone treatment have not been found, it might be ad-
vantageous to forfeit the possible neuroprotective capabilities of 
inflammatory cytokines in favor of the documented benefits of an 
extended progesterone treatment. 
Decompressive Craniectomy
Craniectomy has long been used as a last resort in the treat-
ment of traumatic brain injury. It is only when indicators of 
incredibly high intracranial pressure manifest that craniectomy 
is considered. Such indicators include compression of cortical 
gyri and basal cisterns, signs of immediate herniation, and ce-
rebral swelling (Morgalla, et al. 2008). In the majority of studies 
analyzed, craniectomy was only used after standard protocols 
had failed to lower intracranial pressure sufficiently. As such, it 
is difficult to assess the efficacy of craniectomy, as it is generally 
used only on patients with severe injuries who have already 
undergone other treatments. Usually, by the time a craniectomy 
is performed, there has been a lapse of time between injury and 
the surgery (Morgalla, et al. 2008; Olivecrona, et al. 2007), limit-
ing its benefit. Another hindrance to the study of decompressive 
craniectomy is that due to the surgical nature of the procedure, 
a blinded study is impossible. 
While one study analyzed found decompressive craniectomy 
to lower intracranial pressure but hinder favorable outcome 
(Cooper, et al. 2012), four other studies found that long term 
results justify the surgery (Akyuz, et al. 2010; Morgalla, et al. 
2008; Olivecrona, et al. 2007; Qiu, et al. 2009). Cooper, et al.’s 
2012 study reports that patients who received a craniectomy 
along with standard treatment showed a less favorable outcome 
after six months. However, the mortality rate was the same in 
patients who had undergone the procedure and those who had 
not. In contrast, Olivecrona, et al. (2007) found a 10% difference 
in outcome, with those who received a decompressive craniec-
tomy having the more favorable outcomes when compared to 
patients who received only standard care. 
Patients who had undergone a decompressive craniectomy 
needed fewer interventions to lower intracranial pressure. They 
required a shorter period of time on mechanical ventilation, 
and they spent a shorter amount of time in the intensive care 
unit (Cooper, et al. 2012). There was a significant reduction in 
intracranial pressure directly after the surgery, which later sta-
bilized to manageable levels (Olivecrona, et al. 2007). One study 
found that 40% of patients who were otherwise likely to die had 
favorable results after undergoing a decompressive craniectomy 
(Morgalla, et al. 2008).
There are a number of caveats in regard to craniectomies. 
Firstly, patients who underwent the surgery had a higher in-
cidence of hydrocephalus (Cooper, et al. 2012), which neces-
sitates additional medical or surgical care. Secondly, unilateral 
craniectomies have been linked to delayed intracranial hema-
tomas and subdural effusion, both of which must be treated 
through surgical intervention (Qiu, et al. 2009). However, suc-
cess has been seen in bilateral craniectomies. A problem with 
all decompressive craniectomies seems to be an increase in 
transcapillary leakage. The point of a craniectomy is to allow 
room for swelling. The loss of resistance in the brain leads to 
transcapillary leakage due to an increase in the transcapillary 
hydrostatic pressure gradient. In order to counteract this effect 
of a craniectomy, the transcapillary pressure must be lowered 
by preventing an increase in arterial pressure and infusing albu-
min and packed red blood cells (Olivecrona, et al. 2007). These 
issues are all collateral damage of decompressive craniectomies, 
but the benefit of the surgery seems to outweigh the detriment. 
An important factor to consider is the timing of the procedure. 
While most craniectomies are performed after standard proto-
col has been tried and found unsuccessful, thus lengthening the 
amount of time between the injury and the surgery, this might 
not be the most advantageous use of craniectomies. Akyuz, et al. 
(2010) compared the results of craniectomies on patients who 
received the surgery following standard procedure to those 
who received the surgery immediately. The first group had their 
craniectomies around 35.7 hours after trauma, as compared to 
the second group, who underwent the procedure approximate-
ly 4 hours after trauma. It was found that early decompressive 
craniectomy resulted in a 48% decrease in intracranial pressure. 
The group which underwent standard protocols before receiv-
ing craniectomies yielded a 27.8% favorable outcome as com-
pared to the other group, which had a 50% favorable outcome 
after 12 months. While the best results were found when the 
procedure was performed within 4 hours of injury, performing 
the craniectomy within 48 hours still provides benefit (Qiu, et 
al. 2009). Using craniectomy as a second tier response hinders 
the positive effects of the procedure, as an extended amount of 
time with high intracranial pressure is detrimental to functional 
outcome.
The size of the decompressive craniectomy is also significant. If 
the craniectomy is too small, it will not allow the brain enough 
room to expand. The brain will then swell through the incision, 
causing external herniation. Bilateral craniectomies have the ad-
vantage of providing more space for the brain to expand (Akyuz, 
et al. 2010).
Age is also an integral consideration when determining the out-
come of decompressive craneictomy. In fact, the study done by 
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Cooper, et al. (2012), which found the least favorable results, 
was the study which included the oldest patients. It seems that 
the highest recommended age upon which a craniectomy for 
traumatic brain injury should be performed is 40, and that it is 
detrimental to those over 60 (Akyuz, et al. 2010; Morgalla, et al. 
2008; Olivecrona, et al. 2007). The greatest benefit is to younger 
patients. This might be due to a stronger immune system or to 
an elevated recovery ability in younger patients.
Conclusion
These three responses to traumatic brain injury are still being 
researched. From the studies analyzed, it is apparent that due to 
the negligible benefit and immense cost of using hypertonic sa-
line, it should be reserved for patients with injuries that indicate 
surgery. The status of hypertonic saline as a first tier response 
should be reevaluated. Progesterone, on the other hand, should 
be initiated into standard protocol. It shows no discernable 
harm and has been proven to do much good. It is essential that 
it be included in first tier response, as the immediacy of ad-
ministration bears effect on the amount of good it can do for 
the patient. Decompressive craniectomy should be considered 
immediately in a case of uncontrollable intracranial pressure in 
a relatively young patient, so as to capitalize on the efficacy of a 
rapid craniectomy. In such a case, the gains outweigh potential 
damage. However, all assessments must be made on an individ-
ual basis, as each patient presents a unique set of properties.
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